These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31642004)

  • 1. The pharmacokinetics of 3-fluoroamphetamine following delivery using clinically relevant routes of administration.
    Jiang Y; Ray A; Junaid MSA; Bhattaccharjee SA; Kelley K; Banga AK; Blough BE; Murnane KS
    Drug Deliv Transl Res; 2020 Feb; 10(1):271-281. PubMed ID: 31642004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal Delivery of the Free Base of 3-Fluoroamphetamine: In Vitro Skin Permeation and Irritation Potential.
    Jiang Y; Murnane KS; Blough BE; Banga AK
    AAPS PharmSciTech; 2020 Mar; 21(3):109. PubMed ID: 32215773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of chemical and physical enhancement techniques on transdermal delivery of 3-fluoroamphetamine hydrochloride.
    Puri A; Murnane KS; Blough BE; Banga AK
    Int J Pharm; 2017 Aug; 528(1-2):452-462. PubMed ID: 28633107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation.
    Yang Z; Teng Y; Wang H; Hou H
    Int J Pharm; 2013 Apr; 447(1-2):231-40. PubMed ID: 23467076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preparation and transdermal permeation of triptolide and ferulic acid ethosomes gel
    Tao L; He LF; Guan YM; Chen LH; Zhu WF; Jin C; Wu L
    Zhongguo Zhong Yao Za Zhi; 2018 Mar; 43(6):1139-1144. PubMed ID: 29676120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omeprazole absorption from a compounded transdermal formulation in healthy volunteers.
    Haas CE; Lin L; Cloen D; Kufel T; Moon R; Frerichs V
    J Am Pharm Assoc (2003); 2005; 45(4):473-8. PubMed ID: 16128503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of PEG6000 on the in vitro and in vivo transdermal permeation of ondansetron hydrochloride from EVA1802 membranes.
    Krishnaiah YS; Rama B; Raghumurthy V; Ramanamurthy KV; Satyanarayana V
    Pharm Dev Technol; 2009; 14(1):50-61. PubMed ID: 18819031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic properties of 4-fluoroamphetamine in serum and oral fluid after oral ingestion.
    Toennes SW; Schneider D; Pogoda W; Paulke A; Wunder C; Theunissen EL; Kuypers KPC; de Sousa Fernandes Perna E; Ramaekers JG
    Drug Test Anal; 2019 Jul; 11(7):1028-1034. PubMed ID: 30912312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of in vitro/in vivo correlations for three fentanyl transdermal delivery systems using in vitro skin permeation testing and human pharmacokinetic studies under the influence of transient heat application.
    Shin SH; Yu M; Hammell DC; Ghosh P; Raney SG; Hassan HE; Stinchcomb AL
    J Control Release; 2022 Feb; 342():134-147. PubMed ID: 34838928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and evaluation of dl-praeruptorin A microemulsion based hydrogel for dermal delivery.
    Zhang X; Wu Y; Hong Y; Zhu X; Lin L; Lin Q
    Drug Deliv; 2015; 22(6):757-64. PubMed ID: 24724963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Translational Pharmacokinetic Rat Model of Cerebral Spinal Fluid and Plasma Concentrations of Cefepime.
    Avedissian SN; Pais G; Joshi MD; Rhodes NJ; Scheetz MH
    mSphere; 2019 Jan; 4(1):. PubMed ID: 30700511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement.
    Aboofazeli R; Zia H; Needham TE
    Drug Deliv; 2002; 9(4):239-47. PubMed ID: 12511202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of permeation enhancers on transdermal delivery of fluoxetine: in vitro and in vivo evaluation.
    Jung E; Kang YP; Yoon IS; Kim JS; Kwon SW; Chung SJ; Shim CK; Kim DD
    Int J Pharm; 2013 Nov; 456(2):362-9. PubMed ID: 24012861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of rivastigmine permeation from a transdermal system in the Franz cell using synthetic membranes and pig ear skin with in vivo-in vitro correlation.
    Simon A; Amaro MI; Healy AM; Cabral LM; de Sousa VP
    Int J Pharm; 2016 Oct; 512(1):234-241. PubMed ID: 27568498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single and multiple dose intravenous and oral pharmacokinetics of the hedgehog pathway inhibitor vismodegib in healthy female subjects.
    Graham RA; Hop CE; Borin MT; Lum BL; Colburn D; Chang I; Shin YG; Malhi V; Low JA; Dresser MJ
    Br J Clin Pharmacol; 2012 Nov; 74(5):788-96. PubMed ID: 22458643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal iontophoretic delivery of tacrine hydrochloride: Correlation between in vitro permeation and in vivo performance in rats.
    Patel N; Jain S; Lin S
    Int J Pharm; 2016 Nov; 513(1-2):393-403. PubMed ID: 27633278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal delivery of naloxone: skin permeation, pharmacokinetic, irritancy and stability studies.
    Panchagnula R; Bokalial R; Sharma P; Khandavilli S
    Int J Pharm; 2005 Apr; 293(1-2):213-23. PubMed ID: 15778059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal Delivery of Compounds with Different Lipophilicity and Molecular Weight from W/O Microemulsions Analyzed by UPLC-QTOF/ MS and LC-MS/MS.
    Lin H; Michniak-Kohn B; Xia Z; Xu L; Kang Q; Chen C; Ma S; Wu Q
    Curr Drug Deliv; 2018; 15(7):1009-1019. PubMed ID: 29268684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro-in vivo correlations for nicotine transdermal delivery systems evaluated by both in vitro skin permeation (IVPT) and in vivo serum pharmacokinetics under the influence of transient heat application.
    Shin SH; Thomas S; Raney SG; Ghosh P; Hammell DC; El-Kamary SS; Chen WH; Billington MM; Hassan HE; Stinchcomb AL
    J Control Release; 2018 Jan; 270():76-88. PubMed ID: 29175139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
    Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
    Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.